Skip to main content
Current Neuropharmacology logoLink to Current Neuropharmacology
. 2011 Mar;9(1):244–246. doi: 10.2174/157015911795017407

Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Phencyclidine

Toru Kobayashi 1,2,*, Daisuke Nishizawa 1, Kazutaka Ikeda 1
PMCID: PMC3137191  PMID: 21886598

Abstract

Addictive drugs, such as opioids, ethanol, cocaine, amphetamine, and phencyclidine (PCP), affect many functions of the nervous system and peripheral organs, resulting in severe health problems. G protein-activated inwardly rectifying K+ (GIRK, Kir3) channels play an important role in regulating neuronal excitability through activation of various Gi/o protein-coupled receptors including opioid and CB1 cannabinoid receptors. Furthermore, the channels are directly activated by ethanol and inhibited by cocaine at toxic levels, but not affected by methylphenidate, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) at toxic levels. The primary pharmacological action of PCP is blockade of N-methyl-D-aspartate (NMDA) receptor channels that are associated with its psychotomimetic effects. PCP also interacts with several receptors and channels at relatively high concentrations. However, the molecular mechanisms underlying the various effects of PCP remain to be clarified. Here, we investigated the effects of PCP on GIRK channels using the Xenopus oocyte expression system. PCP weakly but significantly inhibited GIRK channels at micromolar concentrations, but not Kir1.1 and Kir2.1 channels. The PCP concentrations effective in inhibiting GIRK channels overlap clinically relevant brain concentrations in severe intoxication. The results suggest that partial inhibition of GIRK channels by PCP may contribute to some of the toxic effects after overdose.

Keywords: Phencyclidine, GIRK channel, intoxication, Kir channel, Xenopus oocyte.

INTRODUCTION

G protein-activated inwardly rectifying K+ (GIRK) channels (also known as Kir3 channels) are members of a family of inwardly rectifying K+ (Kir) channels that includes seven subfamilies [1]. Four GIRK channel subunits have been identified in mammals [1]. Neuronal GIRK channels are predominantly heteromultimers composed of GIRK1 and GIRK2 subunits in most brain regions or homomultimers composed of GIRK2 subunits in the substantia nigra, whereas atrial GIRK channels are heteromultimers composed of GIRK1 and GIRK4 subunits [2]. GIRK channels play an important role in the inhibitory regulation of neuronal excitability in most brain regions and heart rate through activation of various Gi/o protein-coupled receptors, such as opioid, CB1 cannabinoid, and D2 dopamine receptors [2]. Furthermore, the channels are modulated by various psychoactive agents, such as ethanol, antipsychotics, antidepressants, anesthetics, and hormones [2-11]. Recently, we demonstrated that cocaine at toxic levels inhibited GIRK channels expressed in Xenopus oocytes. In contrast, methylphenidate, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) at toxic levels had little effect on GIRK channels, although these drugs at higher concentrations inhibited the channels to a lesser extent than cocaine [12].

Phencyclidine (PCP) has been used as a drug of abuse, although it was originally developed as a general anesthetic in the 1950s [13, 14]. The primary pharmacological action of PCP is blockade of N-methyl-D-aspartate (NMDA) receptor channels that are associated with its psychotomimetic effects [13, 14]. PCP at relatively high concentrations interacts with several receptors and channels, namely, σ, µ-opioid, nicotinic- and muscarinic-acetylcholine receptors, voltage-gated K+, Na+ and Ca2+ channels, and adenosine triphosphate (ATP)-sensitive K+ channels [14, 15, 16]. However, the molecular mechanisms underlying the various effects of PCP have not yet been sufficiently clarified. In the present study, we investigated the effects of PCP on GIRK channels and other Kir channels using the Xenopus oocyte expression system.

METHODS

For Xenopus oocyte experiments [4, 5], Xenopus laevis oocytes were injected with mRNA for GIRK1/GIRK2 or GIRK1/GIRK4 combinations, GIRK2, Kir1.1, or Kir2.1. The oocytes were incubated at 19°C in Barth's solution and defolliculated after collagenase treatment. Whole-cell currents of the oocytes were recorded with a conventional two-electrode voltage clamp. Oocytes were superfused with a high-potassium solution containing 96 mM K+. The membrane potential was held at -70 mV. The values obtained are expressed as mean ± SEM, with n indicating the number of oocytes tested. PCP was generously provided by Shionogi Pharmaceutical Co. Ltd. (Osaka, Japan).

RESULTS

In Xenopus oocytes injected with GIRK1 and GIRK2 mRNA, PCP reversibly reduced basal GIRK inward currents (Fig. (1A)). Similar results were observed in oocytes injected with either GIRK1 and GIRK4 mRNA or GIRK2 mRNA. However, in oocytes expressing either Kir1.1 or Kir2.1 channels, PCP caused no significant response even at 100 µM (less than 5 nA, n = 4, Fig. (1A)). Additionally, in uninjected oocytes, 100 µM PCP and 3 mM Ba2+, a Kir channel blocker, caused no significant response (Fig. (1A)). The results suggest that PCP inhibits GIRK channels. The inhibition by PCP was concentration-dependent (n = 4, Fig. (1B)).

Fig. (1).

Fig. (1)

Inhibitory effects of PCP on GIRK channels expressed in Xenopus oocytes. (A) Top, in an oocyte injected with GIRK1 and GIRK2 mRNA, current responses to 10 µM and 100 µM PCP and to 3 mM Ba2+, a Kir channel blocker. Middle, in an oocyte injected with Kir1.1 mRNA, current responses to 100 µM PCP and to 3 mM Ba2+. Bottom, in an uninjected oocyte, no significant current responses to 100 µM PCP or 3 mM Ba2+. Asterisks show the zero current level. Bars show the duration of application. (B) Concentration-dependent inhibition of GIRK channels by PCP. The magnitudes of inhibition of GIRK currents by PCP were compared with the current components sensitive to 3 mM Ba2+.

DISCUSSION

We demonstrated that PCP at micromolar concentrations inhibited brain-type GIRK1/2 and GIRK2 channels and atrial-type GIRK1/4 channels expressed in Xenopus oocytes. At 100 ìM or less, the inhibitory effects of PCP were more potent than those of cocaine, methylphenidate, methamphetamine, and MDMA (Fig. (2)). In other Kir channel subfamilies, Kir1.1 and Kir2.1 channels were insensitive to these psychostimulants [12] and PCP, whereas PCP inhibited cardiac ATP-sensitive K+ channels, which comprise four pore-forming Kir6 subunits and four regulatory sulfonylurea receptor subunits, with an IC50 value of approximately 20 µM [16]. Further studies using GIRK/Kir1.1 and GIRK/Kir2.1 chimeric channels and mutant GIRK channels may clarify the critical sites mediating the effects of PCP on GIRK channels.

Fig. (2).

Fig. (2)

Comparison of the effects of five addictive drugs: PCP, cocaine, methylphenidate (MPH), methamphetamine (MAP) and MDMA, on GIRK channels. Drug concentration was 100 µM. The magnitudes of inhibition of GIRK currents by the drugs were compared with the 3 mM Ba2+-sensitive current components. Data except for PCP are from our previous study [12].

The use of PCP as a drug of abuse is an important medical problem. Serum PCP concentrations after overdose were reported to reach up to approximately 10 µM in some postmortem cases, up to 45 µM in one massive overdose case [17], and up to approximately 3.3 µM in some nonfatal cases [18], although serum concentrations in most intoxication cases ranged widely from nanomolar to low micromolar concentrations [17, 18]. Furthermore, the concentrations in the brain were reported to be from 3 to 14-fold higher than those in serum [19]. Additionally, because the early phase elimination rate after administration of PCP is relatively high [19], the peak concentrations would be higher than the concentrations measured. Therefore, the PCP concentrations effective in inhibiting GIRK channels overlap the clinically relevant brain concentrations in severe intoxication or fatal cases.

PCP concentrations in severe intoxication cases are associated with coma, seizures, muscle rigidity, and respiratory arrest [20]. GIRK2 knockout mice show spontaneous seizures and are more susceptible to seizures induced by pentylenetetrazol than wild type mice [21]. Furthermore, GIRK inhibitors can depolarize the membrane potential and induce action potentials [22]. Because GIRK channels play an important role in regulating cell excitability, even partial inhibition of neuronal GIRK channels by PCP might contribute to the incidence of seizures and some of neuropsychiatric complications observed in severe or fatal cases after overdose. GIRK channels may be considered as important molecules mediating the effects of PCP, cocaine, opioids, cannabinoids, and ethanol among addictive drugs.

ACKNOWLEDGEMENTS

We thank Dr. Kansaku Baba for his cooperation. We also thank Dr. Steven C. Hebert (Yale University) and Dr. Lily Y. Jan (University of California, San Francisco) for generously providing Kir1.1 cDNA and Kir2.1 cDNA, respectively. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labour and Welfare of Japan.

REFERENCES

  • 1.Reimann F, Ashcroft FM. Inwardly rectifying potassium channels. Curr. Opin. Cell Biol. 1999;11:503–508. doi: 10.1016/S0955-0674(99)80073-8. [DOI] [PubMed] [Google Scholar]
  • 2.Kobayashi T, Ikeda K. G protein-activated inwardly rectifying potassium channels as potential therapeutic targets. Curr. Pharm. Des. 2006;12:4513–4523. doi: 10.2174/138161206779010468. [DOI] [PubMed] [Google Scholar]
  • 3.Kobayashi T, Ikeda K, Kojima H, Niki H, Yano R, Yoshioka T, Kumanishi T. Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat. Neurosci. 1999;2:1091–1097. doi: 10.1038/16019. [DOI] [PubMed] [Google Scholar]
  • 4.Kobayashi T, Ikeda K, Kumanishi T. Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K+ (GIRK) channels expressed in Xenopus oocytes. Br. J. Pharmacol. 2000;129:1716–1722. doi: 10.1038/sj.bjp.0703224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac) Br. J. Pharmacol. 2003;138:1119–1128. doi: 10.1038/sj.bjp.0705172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology. 2004;29:1841–1851. doi: 10.1038/sj.npp.1300484. [DOI] [PubMed] [Google Scholar]
  • 7.Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine. J. Pharmacol. Sci. 2006;102:278–287. doi: 10.1254/jphs.fp0060708. [DOI] [PubMed] [Google Scholar]
  • 8.Yamakura T, Lewohl JM, Harris RA. Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels. Anesthesiology. 2001;95:144–153. doi: 10.1097/00000542-200107000-00025. [DOI] [PubMed] [Google Scholar]
  • 9.Zhou W, Arrabit C, Choe S, Slesinger PA. Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels. Proc. Natl. Acad. Sci. USA. 2001;98:6482–6487. doi: 10.1073/pnas.111447798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kelly MJ, Ronnekleiv OK, Ibrahim N, Langrange AH, Wager EJ. Estrogen modulation of K+ channel activity in hypothalamic neurons involved in the control of the reproductive axis. Steroids. 2002;67:447–456. doi: 10.1016/s0039-128x(01)00181-7. [DOI] [PubMed] [Google Scholar]
  • 11.Evaul K, Jamnongjit M, Bhagavath B, Hammes SR. Testosterone and progesterone rapidly attenuate plasma membrane Gβγ-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. Mol. Endocrinol. 2007;21:186–196. doi: 10.1210/me.2006-0301. [DOI] [PubMed] [Google Scholar]
  • 12.Kobayashi T, Nishizawa D, Iwamura T, Ikeda K. Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes. Toxicol. In Vitro. 2007;21:656–664. doi: 10.1016/j.tiv.2007.01.009. [DOI] [PubMed] [Google Scholar]
  • 13.O'Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th. New York: McGraw-Hill; 2001. pp. 621–642. [Google Scholar]
  • 14.Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 1991;148:1301–1308. doi: 10.1176/ajp.148.10.1301. [DOI] [PubMed] [Google Scholar]
  • 15.Ffrench-Mullen JMH, Rogawski MA. Phencyclidine block of calcium current in isolated guinea-pig hippocampal neurones. J. Physiol. 1992;456:85–105. doi: 10.1113/jphysiol.1992.sp019328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kokoz YM, Alekseev AE, Povzun AA, Korystova AF, Peres-Saad H. Anesthetic phencyclidine, blocker of the ATP-sensitive potassium channels. FEBS Lett. 1994;337:277–280. doi: 10.1016/0014-5793(94)80208-4. [DOI] [PubMed] [Google Scholar]
  • 17.Budd RD, Liu Y. Phencyclidine concentrations in postmortem body fluids and tissues. J. Toxicol. Clin. Toxicol. 1982;19:843–850. doi: 10.3109/15563658208992517. [DOI] [PubMed] [Google Scholar]
  • 18.Bailey DN. Phencyclidine abuse. Clinical findings and concentrations in biological fluids after nonfatal intoxication. Am. J. Clin. Pathol. 1979;72:795–799. doi: 10.1093/ajcp/72.5.795. [DOI] [PubMed] [Google Scholar]
  • 19.Proksch JW, Gentry WB, Owens SM. The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum. Drug Metab. Dispos. 2000;28:742–747. [PubMed] [Google Scholar]
  • 20.Liden CB, Lovejoy FH.Jr, Costello CE. Phencyclidine. Nine cases of poisoning. JAMA. 1975;234:513–516. doi: 10.1001/jama.234.5.513. [DOI] [PubMed] [Google Scholar]
  • 21.Signorini S, Liao YJ, Duncan SA, Jan LY, Stoffel M. Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2. Proc. Natl. Acad. Sci. USA. 1997;94:923–927. doi: 10.1073/pnas.94.3.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kuzhikandathil EV, Oxford GS. Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels. Mol. Pharmacol. 2002;62:119–126. doi: 10.1124/mol.62.1.119. [DOI] [PubMed] [Google Scholar]

Articles from Current Neuropharmacology are provided here courtesy of Bentham Science Publishers

RESOURCES